ELIZABETH ANDERSON

Allopathic & Osteopathic Physicians|Internal Medicine WILMETTE, IL NPI 1912940552

General Payments — all program years on this page

$8,411.20

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 315
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $906.36 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $899.7120
Education $6.651

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Lilly USA, LLC $324.5412
Amgen Inc. $180.754
Averitas Pharma Inc. $146.571
Bayer HealthCare Pharmaceuticals Inc. $124.261
Kerecis Limited $101.661
Abbott Laboratories $28.582

By program year

Program yearAmountRecords
2018 $2,765.70129
2019 $2,116.4599
2020 $318.4311
2021 $627.4116
2022 $1,075.1829
2023 $601.6710
2024 $906.3621

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086200200 Bayer Healthcare Pharmaceuticals Inc. $124.26 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111517311 Amgen Inc. $124.26 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117190493 Amgen Inc. $15.99 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117190495 Amgen Inc. $19.21 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117190497 Amgen Inc. $21.29 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120117514 Kerecis Limited $101.66 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125336021 Abbott Laboratories $14.29 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125336023 Abbott Laboratories $14.29 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133416771 Averitas Pharma Inc. $146.57 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136155004 Lilly USA, LLC $10.51 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136155006 Lilly USA, LLC $9.78 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136158453 Lilly USA, LLC $6.51 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136158455 Lilly USA, LLC $115.11 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136159381 Lilly USA, LLC $12.79 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136160339 Lilly USA, LLC $6.65 07/08/2024 Education Undisputed 01/23/2026 View at CMS
1136164406 Lilly USA, LLC $13.41 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136164408 Lilly USA, LLC $6.62 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136172470 Lilly USA, LLC $14.20 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136172472 Lilly USA, LLC $7.69 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136172946 Lilly USA, LLC $1.34 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136172948 Lilly USA, LLC $119.93 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.